Peer-reviewed study findings "raise concerns regarding vaccine-induced undetected severe cardiovascular side-effects and underscore the already established causal relationship between vaccines and myocarditis, a frequent cause of unexpected cardiac arrest in young individuals."
EU antitrust regulators charged Apple on Monday with restricting rivals' access to its NFC chip technology in a move that could result in a hefty fine for the iPhone maker and force it to open its mobile payment system to competitors.
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a move toward potentially allowing shots for millions of youths by summer.
In the 19th century, improvements in quality-of-life fundamentals such as drinking water, sanitation, housing and nutrition helped launch the public health profession.
Our public health agencies such as the CDC and NIH, and television medical experts seem unable to address key health messages that could have a dramatic effect in reducing risk of severe sequelae in higher-risk populations such as the minority and African-American population to the scourge of SARS-CoV-2.
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
The U.S. Securities and Exchange Commission (SEC) proposed rules that would force companies to publicly disclose a wide-range of climate-related information.
Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
Pfizer will "no longer initiate new clinical trials in Russia, and we will stop recruiting new patients in our ongoing clinical trials in the country."
